<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02156700</url>
  </required_header>
  <id_info>
    <org_study_id>KBD-IG1</org_study_id>
    <nct_id>NCT02156700</nct_id>
  </id_info>
  <brief_title>Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors</brief_title>
  <official_title>Quantitative Real-time Ultrasound Elastography (Shear Wave Elastography - SWE™) for Characterisation of Liver Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Dubrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Dubrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Shear Wave Elastography (SWE™) is a quantitative elastography method for measuring tissue
      stiffness. The difference in stiffness between benign and malignant tumors has been
      demonstrated by other elastography methods (acoustic radiation force impulse imaging,
      transient elastography and/or magnetic resonance elastography). The investigators
      hypothesized that benign liver tumors are softer than malignant liver tumors measured by
      SWE™, allowing differentiation between the two by tumor stiffness expressed in kilopascal
      (kPa). In this study benign and malignant liver tumors will be evaluated in five groups: 1)
      hemangioma and 2) focal nodular hyperplasia (FNH) representing the most common benign liver
      tumors; 3) metastases and 4) cholangiocarcinoma (CCC), both presenting malignant tumors
      mostly appearing in otherwise healthy liver, and 5) hepatocellular carcinoma (HCC) mostly
      occurring in cirrhotic liver, which can potentially influence elastographic measurements
      therefore querying the appropriateness of comparison between tumors in healthy and cirrhotic
      liver. Enrolled patients will undergo transabdominal ultrasonography and SWE™ examination.
      The tumor stiffness will be measured five times for each tumor. Additionally, surrounding
      liver parenchyma stiffness will be measured. The nature of the liver tumor will be defined
      through a standard diagnostic workup according to current guidelines, including contrast
      enhanced multi-slice CT, MRI and/or cytology/histology, as applicable. In the final analysis
      the mean tumor stiffness and tumor-parenchyma ratio will be calculated for each group as well
      as for benign and malignant tumors separately, and cut-off values for the differentiation of
      various groups will be derived. The clinical value of the method will be appraised based on
      specificity, sensitivity, positive and negative predictive values, and AUC.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tumor stiffness</measure>
    <time_frame>at the time of enrollment</time_frame>
    <description>tumor stiffness expressed in kPa, measured by ShearWave ™ Elastography (SWE™) Aixplorer® ultrasound machine from SuperSonic Imagine, Aix-en-Provence, France</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>tumor to parenchyma stiffness ratio</measure>
    <time_frame>at the time of enrollment</time_frame>
    <description>comparison between tumor and surrounding liver parenchyma stiffness as expressed by tumor to liver parenchyma stiffness ratio</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">196</enrollment>
  <condition>Haemangioma</condition>
  <condition>Metastases</condition>
  <condition>Cholangiocellular Carcinoma</condition>
  <condition>Hepatocellular Carcinoma</condition>
  <condition>Focal Nodular Hyperplasia</condition>
  <arm_group>
    <arm_group_label>Liver tumors</arm_group_label>
    <description>Measurement of tumor stiffness by Shear wave elastography - SWE™</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Shear wave elastography</intervention_name>
    <description>Measurement of tumor stiffness by Shear wave elastography - SWE™</description>
    <arm_group_label>Liver tumors</arm_group_label>
    <other_name>Shear wave elastography - SWE™</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        outpatients and inpatients in a tertiary care hsopital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  liver tumors detected on US examination of the liver

          -  compliance to the study protocol

          -  signed approval for the diagnostic ultrasound with SWE™

        Exclusion Criteria:

          -  haemangioma, focal nodular hyperplasia (FNH), metastasis, cholangiocellular carcinoma
             (CCC) or hepatocellular carcinoma (HCC) in the proximity of liver capsule (less than 1
             cm from the liver surface)

          -  haemangioma, FNH, metastasis, CCC or HCC deep in the lever parenchyma (more than 7 cm
             away from the surface)

          -  liver tumors other than haemangioma, FNH, metastasis, CCC and HCC

          -  severe hepatitis defined by alanine aminotransferase (ALT) values &gt; 5 x upper limit of
             normal (ULN)

          -  obstructive jaundice

          -  congestive heart failure

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ivica Grgurevic, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Dubrava</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Dubrava</name>
      <address>
        <city>Zagreb</city>
        <zip>10040</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <reference>
    <citation>Masuzaki R, Tateishi R, Yoshida H, Sato T, Ohki T, Goto T, Yoshida H, Sato S, Sugioka Y, Ikeda H, Shiina S, Kawabe T, Omata M. Assessing liver tumor stiffness by transient elastography. Hepatol Int. 2007 Sep;1(3):394-7. doi: 10.1007/s12072-007-9012-7. Epub 2007 Jul 21.</citation>
    <PMID>19669335</PMID>
  </reference>
  <reference>
    <citation>Davies G, Koenen M. Acoustic radiation force impulse elastography in distinguishing hepatic haemangiomata from metastases: preliminary observations. Br J Radiol. 2011 Oct;84(1006):939-43. doi: 10.1259/bjr/97637841. Epub 2011 Mar 8.</citation>
    <PMID>21385910</PMID>
  </reference>
  <reference>
    <citation>Cho SH, Lee JY, Han JK, Choi BI. Acoustic radiation force impulse elastography for the evaluation of focal solid hepatic lesions: preliminary findings. Ultrasound Med Biol. 2010 Feb;36(2):202-8. doi: 10.1016/j.ultrasmedbio.2009.10.009. Epub 2009 Dec 16.</citation>
    <PMID>20018432</PMID>
  </reference>
  <reference>
    <citation>Heide R, Strobel D, Bernatik T, Goertz RS. Characterization of focal liver lesions (FLL) with acoustic radiation force impulse (ARFI) elastometry. Ultraschall Med. 2010 Aug;31(4):405-9. doi: 10.1055/s-0029-1245565. Epub 2010 Jul 22.</citation>
    <PMID>20652853</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2014</study_first_submitted>
  <study_first_submitted_qc>June 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2014</study_first_posted>
  <last_update_submitted>December 23, 2015</last_update_submitted>
  <last_update_submitted_qc>December 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Dubrava</investigator_affiliation>
    <investigator_full_name>Ivica Grgurevic, MD</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>shear wave elastography</keyword>
  <keyword>haemangiomas</keyword>
  <keyword>metastases</keyword>
  <keyword>hepatocellular carcinoma</keyword>
  <keyword>focal nodular hyperplasia</keyword>
  <keyword>cholangiocellular carcinoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
    <mesh_term>Hyperplasia</mesh_term>
    <mesh_term>Hemangioma</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Focal Nodular Hyperplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

